Tadakazu Shimoda

Author PubWeight™ 83.91‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer 2000 8.85
2 Incidence of lymph node metastasis and the feasibility of endoscopic resection for undifferentiated-type early gastric cancer. Gastric Cancer 2009 4.04
3 Early detection of superficial squamous cell carcinoma in the head and neck region and esophagus by narrow band imaging: a multicenter randomized controlled trial. J Clin Oncol 2010 3.64
4 Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer. Nat Genet 2008 2.89
5 Correlations between lymph node metastasis and depth of submucosal invasion in submucosal invasive colorectal carcinoma: a Japanese collaborative study. J Gastroenterol 2004 2.88
6 Gastrointestinal stromal tumor: consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB-1 grade. Hum Pathol 2002 2.45
7 Nonpolypoid neoplastic lesions of the colorectal mucosa. Gastrointest Endosc 2008 2.09
8 Efficacy of the invasive/non-invasive pattern by magnifying chromoendoscopy to estimate the depth of invasion of early colorectal neoplasms. Am J Gastroenterol 2008 2.05
9 Changing trends in the proportion of adenocarcinoma of the esophagogastric junction in a large tertiary referral center in Japan. J Gastroenterol Hepatol 2008 1.93
10 Usefulness and safety of 0.4% sodium hyaluronate solution as a submucosal fluid "cushion" in endoscopic resection for gastric neoplasms: a prospective multicenter trial. Gastrointest Endosc 2007 1.86
11 Histopathological criteria for additional treatment after endoscopic mucosal resection for esophageal cancer: analysis of 464 surgically resected cases. Mod Pathol 2006 1.68
12 Hedgehog signal activation in gastric pit cell and in diffuse-type gastric cancer. Gastroenterology 2006 1.60
13 Two distinct pathways of tumorigenesis of adenocarcinomas of the esophagogastric junction, related or unrelated to intestinal metaplasia. Pathol Int 2007 1.50
14 Clinicopathologic study of primary malignant gastrointestinal stromal tumor of the stomach, with special reference to prognostic factors: analysis of results in 140 surgically resected patients. Gastric Cancer 2003 1.48
15 Carcinoid tumor arising in a duplication cyst of the duodenum. Pathol Int 2006 1.33
16 Does autofluorescence imaging videoendoscopy system improve the colonoscopic polyp detection rate?--a pilot study. Am J Gastroenterol 2008 1.33
17 Distinct gene expression-defined classes of gastrointestinal stromal tumor. J Clin Oncol 2008 1.31
18 Predictive histopathologic factors for lymph node metastasis in patients with nonpedunculated submucosal invasive colorectal carcinoma. Dis Colon Rectum 2005 1.26
19 Identification of prognostic biomarkers in gastric cancer using endoscopic biopsy samples. Cancer Sci 2008 1.23
20 Impact of insulin-like growth factor type 1 receptor, epidermal growth factor receptor, and HER2 expressions on outcomes of patients with gastric cancer. Clin Cancer Res 2008 1.19
21 A functional single nucleotide polymorphism in mucin 1, at chromosome 1q22, determines susceptibility to diffuse-type gastric cancer. Gastroenterology 2010 1.17
22 Less aggressive features of colorectal cancer with liver metastases showing macroscopic intrabiliary extension. Pathol Int 2002 1.16
23 Differential diagnosis of gastrointestinal stromal tumor and other spindle cell tumors in the gastrointestinal tract based on immunohistochemical analysis. Virchows Arch 2004 1.13
24 Clinicopathological analysis of early-stage gastric cancers detected after successful eradication of Helicobacter pylori. Helicobacter 2011 1.12
25 Clinical significance of insulin-like growth factor type 1 receptor and epidermal growth factor receptor in patients with advanced gastric cancer. Oncology 2008 1.11
26 Pathological prognostic factors predicting lymph node metastasis in submucosal invasive (T1) colorectal carcinoma. Mod Pathol 2010 1.11
27 Myxoid epithelioid gastrointestinal stromal tumor (GIST) with mast cell infiltrations: a subtype of GIST with mutations of platelet-derived growth factor receptor alpha gene. Hum Pathol 2004 1.10
28 Beta-catenin mutations in sporadic fundic gland polyps. Virchows Arch 2001 1.09
29 Bizarre parosteal osteochondromatous proliferation with a t(1;17) translocation. Virchows Arch 2005 1.05
30 Histologic and immunohistochemical analyses of α-fetoprotein--producing cancer of the stomach. Am J Surg Pathol 2012 1.02
31 Pragmatic classification of superficial neoplastic colorectal lesions. Gastrointest Endosc 2009 1.02
32 Phase II trial of paclitaxel and cisplatin as neoadjuvant chemotherapy for locally advanced gastric cancer. Cancer Chemother Pharmacol 2013 1.01
33 Pfetin as a prognostic biomarker of gastrointestinal stromal tumors revealed by proteomics. Clin Cancer Res 2008 1.00
34 Prospective evaluation of prognostic factors in patients with colorectal cancer undergoing curative resection. J Surg Oncol 2003 1.00
35 Frequent hypermethylation of RASSF1A in early flat-type colorectal tumors. Oncogene 2004 0.99
36 CD10 expression in colorectal carcinoma correlates with liver metastasis. Dis Colon Rectum 2005 0.97
37 Two cases of early-stage esophageal malignant melanoma with long-term survival. Pathol Int 2008 0.97
38 Enteropathy-type T-cell lymphoma showing repeated small bowel rupture and refractoriness to chemotherapy: a case report. Jpn J Clin Oncol 2002 0.96
39 Cyclooxygenase-2 overexpression associated with a poor prognosis in chondrosarcomas. Hum Pathol 2006 0.94
40 Size does not determine the grade of malignancy of early invasive colorectal cancer. World J Gastroenterol 2009 0.93
41 Fluorescence in situ hybridization analysis of extraskeletal myxoid chondrosarcomas using EWSR1 and NR4A3 probes. Hum Pathol 2009 0.92
42 Multi-institutional study of risk factors of liver metastasis from colorectal cancer: correlation with CD10 expression. Int J Colorectal Dis 2010 0.92
43 High-grade dysplasia associated with fundic gland polyposis in a familial adenomatous polyposis patient, with special reference to APC mutation profiles. Mod Pathol 2004 0.92
44 Cancer invasion to Auerbach's plexus is an important prognostic factor in patients with pT3-pT4 colorectal cancer. Dis Colon Rectum 2007 0.91
45 Alpha-fetoprotein-producing carcinoma of the colon: report of a case and review of the literature. Dis Colon Rectum 2003 0.90
46 Vascular endothelial growth factor receptor expression as a prognostic marker for survival in colorectal cancer. Jpn J Clin Oncol 2009 0.89
47 Nucleostemin and TWIST as predictive markers for recurrence after neoadjuvant chemotherapy for esophageal carcinoma. Cancer Sci 2011 0.89
48 Usefulness and safety of 0.4% sodium hyaluronate solution as a submucosal fluid "cushion" for endoscopic resection of colorectal mucosal neoplasms: a prospective multi-center open-label trial. BMC Gastroenterol 2009 0.89
49 Adenosquamous carcinoma of the esophagus. Clinicopathologic study of 18 cases. Oncology 2004 0.88
50 Clinicopathological characteristics and prognosis of rectal well-differentiated neuroendocrine tumors. Int J Colorectal Dis 2008 0.87
51 Risk of lymph node metastasis in patients with pedunculated type early invasive colorectal cancer: a retrospective multicenter study. Cancer Sci 2011 0.87
52 Clinicopathological characteristics and prognostic factors of advanced colorectal mucinous adenocarcinoma. Histopathology 2012 0.86
53 Advantage of FISH analysis using FKHR probes for an adjunct to diagnosis of rhabdomyosarcomas. Virchows Arch 2008 0.86
54 Nucleophosmin as a candidate prognostic biomarker of Ewing's sarcoma revealed by proteomics. Clin Cancer Res 2009 0.86
55 Peroxiredoxin 2 as a chemotherapy responsiveness biomarker candidate in osteosarcoma revealed by proteomics. Proteomics Clin Appl 2010 0.86
56 Usefulness of Ki-67 for predicting the metastatic potential of rectal carcinoids. Pathol Int 2006 0.85
57 Relationships of insulin-like growth factor-1 receptor and epidermal growth factor receptor expression to clinical outcomes in patients with colorectal cancer. Oncology 2008 0.85
58 Five-year incidence of advanced neoplasia after initial colonoscopy in Japan: a multicenter retrospective cohort study. Jpn J Clin Oncol 2009 0.84
59 Correlation between endoscopic macroscopic type and invasion depth for early esophagogastric junction adenocarcinomas. Gastric Cancer 2011 0.84
60 Esophageal basaloid carcinoma with marked myoepithelial differentiation. Pathol Int 2002 0.84
61 Appraisal of a revised lymph node classification system for esophageal squamous cell cancer. Ann Thorac Surg 2007 0.84
62 Endoscopic diagnosis of cytomegalovirus gastritis after allogeneic hematopoietic stem cell transplantation. World J Gastroenterol 2010 0.84
63 Interobserver variability in histologic recognition, interpretation of KIT immunostaining, and determining MIB-1 labeling indices in gastrointestinal stromal tumors and other spindle cell tumors of the gastrointestinal tract. Appl Immunohistochem Mol Morphol 2006 0.84
64 Different histological status of gastritis in superficial adenocarcinoma of the esophagogastric junction. Jpn J Clin Oncol 2013 0.83
65 Analysis of CHOP rearrangement in pleomorphic liposarcomas using fluorescence in situ hybridization. Cancer Sci 2008 0.82
66 [Endoscopic diagnosis of gastric cancer invasion depth]. Nihon Shokakibyo Gakkai Zasshi 2009 0.81
67 Quantification of CD10 mRNA in colorectal cancer and relationship between mRNA expression and liver metastasis. Anticancer Res 2007 0.80
68 Comparative study of Western and Japanese criteria for biopsy-based diagnosis of gastric epithelial neoplasia. Gastric Cancer 2014 0.79
69 Pfetin as a prognostic biomarker in gastrointestinal stromal tumor: novel monoclonal antibody and external validation study in multiple clinical facilities. Jpn J Clin Oncol 2009 0.79
70 Impact of vascular endothelial growth factor receptor 1, 2, and 3 expression on the outcome of patients with gastric cancer. Cancer Sci 2009 0.79
71 Result of an endoscopic mucosal resection demonstrated at the International Gastric Cancer Congress in New York. Gastric Cancer 2002 0.79
72 Association of gastric and intestinal phenotypic marker expression of gastric carcinomas with tumor thymidylate synthase expression and response to postoperative chemotherapy with 5-fluorouracil. J Cancer Res Clin Oncol 2003 0.79
73 The prognostic significance of isolated tumor cells in the lymph nodes of gastric cancer patients. Gastric Cancer 2010 0.79
74 Determination of the optimal cutoff percentage of residual tumors to define the pathological response rate for gastric cancer treated with preoperative therapy (JCOG1004-A). Gastric Cancer 2014 0.78
75 Combination of O6-methylguanine-DNA methyltransferase and thymidylate synthase for the prediction of fluoropyrimidine efficacy. Eur J Cancer 2007 0.78
76 Distribution of the deepest penetrating point of minute submucosal gastric cancer. Jpn J Clin Oncol 2005 0.76
77 Utility of immunohistochemical analysis for cyclo-oxygenase 2 in the differential diagnosis of osteoblastoma and osteosarcoma. J Clin Pathol 2006 0.75
78 A case of gastric-type adenoma with chief cell and parietal cell differentiation surrounded by complete intestinal metaplasia. Nihon Shokakibyo Gakkai Zasshi 2017 0.75
79 Successful treatment of a primary gastric T-cell lymphoma lacking the human T-cell leukemia virus type 1. Hepatogastroenterology 2010 0.75
80 Esophageal squamous cell carcinoma presenting with systemic arterial embolism. Pathol Int 2007 0.75
81 A rare case of poorly differentiated endocrine cell carcinoma of the stomach with signet ring cell differentiation. Gastric Cancer 2010 0.75
82 Long-term survivor of gastric small cell carcinoma. Hepatogastroenterology 2004 0.75
83 Difference in cytoplasmic localization pattern of neutral mucin among lobular endocervical glandular hyperplasia, adenoma malignum, and common adenocarcinoma of the uterine cervix. Virchows Arch 2003 0.75
84 [Recent pathological knowledge of esophago-gastric junction, Barrett's esophagus and its carcinoma]. Nihon Shokakibyo Gakkai Zasshi 2008 0.75
85 Diagnosis and evaluation of intestinal graft-versus-host disease after allogeneic hematopoietic stem cell transplantation following reduced-intensity and myeloablative conditioning regimens. Int J Hematol 2013 0.75